3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Rectal Neoplasms
9
Triple Negative Breast Neoplasms
7
Stomach Neoplasms
7
Colorectal Neoplasms
6
Adenocarcinoma
6
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Adenocarcinoma Of Esophagus
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Neoplasms
4
Nasopharyngeal Carcinoma
4
Neoplasms
3
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Biliary Tract Neoplasms
2
Advanced Solid Tumour
2
Solid Tumors
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Locally Advanced Gastric Cancer
1
HIV Infections
1
HER2-positive Gastric Cancer
1
HER2-positive Breast Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Steroids
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Mastectomy, Segmental
1
Hormones
1
High-Energy Shock Waves
1
Cyclin-Dependent Kinase Inhibitor p18
1
Cyclin-Dependent Kinase Inhibitor p16
1
CT-P6
1
Biopsy
1
Ado-Trastuzumab Emtansine
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
Capecitabine
×
30 days
×
Clear all
No trials found.